Bidirectional relationship between nonalcoholic fatty liver disease and sarcopenia： New insights and perspectives
10.3969/j.issn.1001-5256.2023.11.025
- VernacularTitle:非酒精性脂肪性肝病与肌少症双向关系的新见解与展望
- Author:
Gong FENG
1
;
Yilin REN
2
;
Yonghong MA
3
;
Tianyue WU
2
;
Jiayi ZHANG
4
;
Xiaoni YAN
3
;
Juanjuan SONG
3
;
Xueping LI
5
;
Man MI
1
Author Information
1. Institute of General Practice，Xi’an Medical University， Xi’an 710021， China
2. School of General Practice，Xi’an Medical University， Xi’an 710021， China
3. School of Public Health，Xi’an Medical University， Xi’an 710021， China
4. School of Medical Technology，Xi’an Medical University， Xi’an 710021， China
5. School of Clinical Medicine， Xi’an Medical University， Xi’an 710021， China
- Publication Type:Review
- Keywords:
Sarcopenia;
Non-alcoholic Fatty Liver Disease;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(11):2682-2688
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease （NAFLD） is a group of highly heterogeneous diseases closely associated with metabolic dysfunction. Sarcopenia is a syndrome caused by a continuous decline in muscle mass， strength， and function， and it is often accompanied by NAFLD. Insulin resistance is the main pathological mechanism for sarcopenia and NAFLD， and in addition， factors such as changes in proteins and branched-chain amino acid， hyperammonemia， intestinal flora， and endocrine dysfunction can also lead to sarcopenia and NAFLD. With the deepening of clinical research， many published prospective studies have confirmed the existence of a bidirectional and complex pathophysiological relationship between sarcopenia and NAFLD. This article reviews the bidirectional relationship between sarcopenia and NAFLD， discusses the common pathogenesis of sarcopenia and NAFLD， summarizes the challenges faced in this field， and proposes new directions for the research on the bidirectional relationship between NAFLD and sarcopenia.
